News Focus
News Focus
icon url

HappyLibrarian

03/22/18 8:25 AM

#163223 RE: Kam8 #163206

It sure would be nice if NWBO could have one staff memeber - just one - find and verify these stories and put ia professional looking on the website.

Instead NWBO has the same three out-of-date testimonials.

That would send a much stronger message to current and potential investors.
icon url

hankmanhub

03/22/18 8:41 AM

#163225 RE: Kam8 #163206

Although not always the case for all GBM patients receiving DCVax-L, I have met some long-term GBM survivors treated with DCVax-L at UCLA. They include: Jennifer Sugioka, a 17 year GBM survivor; Brad Silver, a 14 year GBM survivor; Elijah Luyten, MD, a 10 year GBM survivor; Gallia Kistler, a 6 year GBM survivor; and, Jamil Newirth, a 6 year GBM survivor.

icon url

iclight

03/22/18 8:50 AM

#163228 RE: Kam8 #163206

Been discussed before.

1) She didn't receive DCVax til 15 years AFTER her stage II brain tumor diagnosis.
2) She received it after her 3rd surgery at UCLA for Grade III Anaplastic Astrocytoma, not GBM. That was in 2013. She was first diagnosed in 1998.

I'm glad she is doing well, but you are either ignorant of her story or are being purposefully dishonest.

Not really sure how she got in the P2 trial with AA (not GBM). Perhaps at the time (prior to the clinical hold) the company offered compassionate use.
icon url

Kam8

03/22/18 9:09 AM

#163235 RE: Kam8 #163206

Dcvax L saved his life too

Dcvax saved too many patients. This is the facts, no one can change

https://www.riverbendcancerservices.org/single-post/2017/10/04/Survivor-Spotlight-Nate-Bilinski